Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation

Nicole C. Panarelli, Cecily P. Vaughn, Wade S. Samowitz, Rhonda K. Yantiss

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Most sporadic colonic adenocarcinomas are microsatellite stable (MSS) and arise from conventional adenomas by dysregulation of the APC/β-catenin/Wnt signaling pathway. Sporadic adenocarcinomas with a high degree of microsatellite instability (MSI) likely arise from sessile serrated polyps through the serrated neoplastic pathway. These polyps contain BRAF mutations and are prone to epigenetic methylation that ultimately silences MLH1, leading to MSI and heralding progression of dysplasia to invasive adenocarcinoma. Most investigators believe that these 2 models of cancer progression are mutually exclusive, although recent studies describe Wnt signaling activation in serrated polyps and propose that it plays a role in the development of sporadic colonic adenocarcinomas with MSI. We sought to test this hypothesis by evaluating β-catenin immunoexpression in 44 sporadic microsatellite unstable adenocarcinomas and 44 MSS colon cancers. We defined sporadic MSI-high carcinomas as those with loss of MLH1 and PMS2 immunostaining and BRAF V600E mutations that occurred in patients 50 years of age or older without a family history of colonic adenocarcinoma or Lynch syndrome. Forty-one (93%) of these carcinomas displayed membranous β-catenin staining only, compared with 28 (64%) site-matched MSS tumors with abnormal nuclear β-catenin staining.

Original languageEnglish (US)
Pages (from-to)313-317
Number of pages5
JournalAmerican Journal of Surgical Pathology
Volume39
Issue number3
DOIs
StatePublished - Feb 28 2015
Externally publishedYes

Fingerprint

Microsatellite Instability
Colonic Neoplasms
Catenins
Adenocarcinoma
Microsatellite Repeats
Polyps
Staining and Labeling
Carcinoma
Hereditary Nonpolyposis Colorectal Neoplasms
Mutation
Wnt Signaling Pathway
Epigenomics
Adenoma
Methylation
Neoplasms
Research Personnel

Keywords

  • APC
  • BRAF
  • serrated neoplastic pathway
  • sessile serrated polyp
  • β-catenin

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery
  • Medicine(all)

Cite this

Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation. / Panarelli, Nicole C.; Vaughn, Cecily P.; Samowitz, Wade S.; Yantiss, Rhonda K.

In: American Journal of Surgical Pathology, Vol. 39, No. 3, 28.02.2015, p. 313-317.

Research output: Contribution to journalArticle

@article{3b00c872d4e5449789c8b65addec0bb3,
title = "Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation",
abstract = "Most sporadic colonic adenocarcinomas are microsatellite stable (MSS) and arise from conventional adenomas by dysregulation of the APC/β-catenin/Wnt signaling pathway. Sporadic adenocarcinomas with a high degree of microsatellite instability (MSI) likely arise from sessile serrated polyps through the serrated neoplastic pathway. These polyps contain BRAF mutations and are prone to epigenetic methylation that ultimately silences MLH1, leading to MSI and heralding progression of dysplasia to invasive adenocarcinoma. Most investigators believe that these 2 models of cancer progression are mutually exclusive, although recent studies describe Wnt signaling activation in serrated polyps and propose that it plays a role in the development of sporadic colonic adenocarcinomas with MSI. We sought to test this hypothesis by evaluating β-catenin immunoexpression in 44 sporadic microsatellite unstable adenocarcinomas and 44 MSS colon cancers. We defined sporadic MSI-high carcinomas as those with loss of MLH1 and PMS2 immunostaining and BRAF V600E mutations that occurred in patients 50 years of age or older without a family history of colonic adenocarcinoma or Lynch syndrome. Forty-one (93{\%}) of these carcinomas displayed membranous β-catenin staining only, compared with 28 (64{\%}) site-matched MSS tumors with abnormal nuclear β-catenin staining.",
keywords = "APC, BRAF, serrated neoplastic pathway, sessile serrated polyp, β-catenin",
author = "Panarelli, {Nicole C.} and Vaughn, {Cecily P.} and Samowitz, {Wade S.} and Yantiss, {Rhonda K.}",
year = "2015",
month = "2",
day = "28",
doi = "10.1097/PAS.0000000000000380",
language = "English (US)",
volume = "39",
pages = "313--317",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation

AU - Panarelli, Nicole C.

AU - Vaughn, Cecily P.

AU - Samowitz, Wade S.

AU - Yantiss, Rhonda K.

PY - 2015/2/28

Y1 - 2015/2/28

N2 - Most sporadic colonic adenocarcinomas are microsatellite stable (MSS) and arise from conventional adenomas by dysregulation of the APC/β-catenin/Wnt signaling pathway. Sporadic adenocarcinomas with a high degree of microsatellite instability (MSI) likely arise from sessile serrated polyps through the serrated neoplastic pathway. These polyps contain BRAF mutations and are prone to epigenetic methylation that ultimately silences MLH1, leading to MSI and heralding progression of dysplasia to invasive adenocarcinoma. Most investigators believe that these 2 models of cancer progression are mutually exclusive, although recent studies describe Wnt signaling activation in serrated polyps and propose that it plays a role in the development of sporadic colonic adenocarcinomas with MSI. We sought to test this hypothesis by evaluating β-catenin immunoexpression in 44 sporadic microsatellite unstable adenocarcinomas and 44 MSS colon cancers. We defined sporadic MSI-high carcinomas as those with loss of MLH1 and PMS2 immunostaining and BRAF V600E mutations that occurred in patients 50 years of age or older without a family history of colonic adenocarcinoma or Lynch syndrome. Forty-one (93%) of these carcinomas displayed membranous β-catenin staining only, compared with 28 (64%) site-matched MSS tumors with abnormal nuclear β-catenin staining.

AB - Most sporadic colonic adenocarcinomas are microsatellite stable (MSS) and arise from conventional adenomas by dysregulation of the APC/β-catenin/Wnt signaling pathway. Sporadic adenocarcinomas with a high degree of microsatellite instability (MSI) likely arise from sessile serrated polyps through the serrated neoplastic pathway. These polyps contain BRAF mutations and are prone to epigenetic methylation that ultimately silences MLH1, leading to MSI and heralding progression of dysplasia to invasive adenocarcinoma. Most investigators believe that these 2 models of cancer progression are mutually exclusive, although recent studies describe Wnt signaling activation in serrated polyps and propose that it plays a role in the development of sporadic colonic adenocarcinomas with MSI. We sought to test this hypothesis by evaluating β-catenin immunoexpression in 44 sporadic microsatellite unstable adenocarcinomas and 44 MSS colon cancers. We defined sporadic MSI-high carcinomas as those with loss of MLH1 and PMS2 immunostaining and BRAF V600E mutations that occurred in patients 50 years of age or older without a family history of colonic adenocarcinoma or Lynch syndrome. Forty-one (93%) of these carcinomas displayed membranous β-catenin staining only, compared with 28 (64%) site-matched MSS tumors with abnormal nuclear β-catenin staining.

KW - APC

KW - BRAF

KW - serrated neoplastic pathway

KW - sessile serrated polyp

KW - β-catenin

UR - http://www.scopus.com/inward/record.url?scp=84924049990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924049990&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000380

DO - 10.1097/PAS.0000000000000380

M3 - Article

C2 - 25602793

AN - SCOPUS:84924049990

VL - 39

SP - 313

EP - 317

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 3

ER -